Brief: Geneuro Says A First Patient Has Entered The ProTEct-MS Study Extension
21/09/2021 17:30
Sept 21 (Reuters) - Geneuro SA GNRO.PA :
* GENEURO ANNOUNCES THAT A FIRST PATIENT THAT COMPLETED THE
PROTECT-MS STUDY AT THE KAROLINSKA INSTITUTE'S SPECIALISED
ACADEMIC CENTRE HAS ENTERED THE STUDY EXTENSION
* THE RESULTS OF THE PROTECT-MS STUDY ARE STILL EXPECTED IN
THE
FIRST QUARTER OF 2022
Source text for Eikon: ID:nBw9F24Gna
Further company coverage: GNRO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Geneuro SA
See all newsBrief: Geneuro SA Postpones Publication Of Half-Yearly Financial Report
Brief: Geneuro SA Announces Extension Of Its Definitive Debt-Restructuring Moratorium
Brief: Geneuro SA Announces The Opening Of Receivership Proceedings For Its French Subsidiary Geneuro Innovation Sas
Brief: Geneuro Confirms Top-Line Results In Its Post-Covid Trial By End-June
Brief: Geneuro announces EUR 5 Mln private placement